Hewlett Packard Enterprise (HPE) Form 4 Reports Share Sale and RSU Dividend Credits
Rhea-AI Filing Summary
Maeve C. Culloty, EVP, President & CEO Financial Services at Hewlett Packard Enterprise Co (HPE), reported a sale and receipt of dividend-equivalent rights. On 09/23/2025 she sold 3,738 shares of HPE common stock at $25.12 per share, leaving 0 shares reported as directly owned after the sale. An indirect holding of 27.234 shares is reported By Vanguard. On 07/17/2025 dividend-equivalent rights were credited for previously granted restricted stock units: 19.1599, 70.9851, and 742.6539, reflected as underlying common stock amounts of 3,307.5688, 11,923.8101, and 121,421.2226 respectively.
Positive
- Dividend-equivalent rights credited for previously granted RSUs on 07/17/2025 (19.1599, 70.9851, 742.6539)
- Detailed disclosure of both non-derivative transaction and RSU dividend-equivalent credits consistent with Section 16 reporting
Negative
- Disposition of 3,738 shares on 09/23/2025 at $25.12 reduced reported direct ownership to 0 shares
- Direct beneficial ownership appears to be zero after the reported sale
Insights
TL;DR: Insiders sold shares and received dividend-equivalent credits; direct ownership now reported as zero.
The Form 4 records a single open-market sale of 3,738 shares at $25.12 and the crediting of dividend-equivalent rights tied to prior RSU grants on 07/17/2025. The sale reduced reported direct common stock ownership to zero while an indirect holding of 27.234 shares is held via Vanguard. The document provides transactional details but no forward-looking commentary or additional compensation changes.
TL;DR: Routine Section 16 disclosure showing a discretionary sale and routine RSU dividend-equivalent credits.
The filing is a standard Statement of Changes in Beneficial Ownership. It discloses an open-market disposition and the administrative crediting of dividend-equivalent units for previously granted RSUs. Signatures indicate the filing was executed by an attorney-in-fact. There are no disclosures of new grants, option exercises, or agreements beyond the credited dividend equivalents.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,738 | $25.12 | $94K |
| holding | Common Stock | -- | -- | -- |
| Grant/Award | Restricted Stock Units | 19.16 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 70.985 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 742.654 | $0.00 | -- |
Footnotes (1)
- Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. As previously reported, on 12/08/22, the reporting person was granted 9,208 Restricted Stock Units ("RSUs"), 3,069 of which vested on each of 12/08/23 and 12/08/24, and 3,070 of which will vest on 12/08/25. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 19.1599 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25. As previously reported, on 12/07/23, the reporting person was granted 17,060 RSUs, 5,686 of which vested on 12/07/24 and 5,687 of which will vest on each of 12/07/25 and 12/07/26. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 70.9851 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25. As previously reported, on 12/09/24, the reporting person was granted 118,996 RSUs, 39,665 of which will vest on each of 12/09/25 and 12/09/26, and 39,666 of which will vest on12/09/27. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 742.6539 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25.
